They don't need to partner at all. You just want your short term gains so you can sell and move on.
Us long termers are happy for them to go at it alone, have you any idea how well cardiocel is doing!? Do the maths on the numbers and you will find out.
Marketing and RnD costs haven't been very expensive at all. Not to mention the rebate on RnD costs anyway.
With 35million cash after this quarter, at current 11mil loss for HY rates, we will have cash for Atleast another 1.5years. (That loss included Atleast 3-5mil from vaccines)
And that's not including increases in revenue.. Which are just starting to go bang.
Very soon revenue will outweigh costs, when that happens the sky will be the limit.
I'm done. Not even gona go into the vaccine division.
ahz chart, page-232
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.61 |
Change
-0.560(2.78%) |
Mkt cap ! $376.9M | |||
| Open | High | Low | Value | Volume |
| $20.18 | $20.20 | $19.60 | $178.1K | 8.889K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 61 | $19.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.60 |
Change
-0.560 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| $20.04 | $20.04 | $19.60 | 223 | ||
| Last updated 15.49pm 17/05/2024 ? | |||||
| AVR (ASX) Chart |